TCF7L2 (Transcription Factor 7-Like 2)

Migration, Crosslink

📖

TCF7L2 (Transcription Factor 7-Like 2)

active

wiki page Created: 2026-04-02T07:19:30 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-tcf7l2

📖 Wiki Page

gene955 wordssynced 2026-04-02

TCF7L2 (Transcription Factor 7-Like 2)

<div class="infobox" style="float: right; width: 300px; background: #f5f5f5; border: 1px solid #ddd; padding: 10px; margin: 0 0 10px 10px;">
<h3 style="margin-top: 0; border-bottom: 1px solid #ddd;">TCF7L2</h3>
<table style="font-size: 0.9em; width: 100%;">
<tr><td><b>Gene Symbol</b></td><td>TCF7L2</td></tr>
<tr><td><b>Common Names</b></td><td>TCF4, T-cell factor 4</td></tr>
<tr><td><b>Protein</b></td><td>[TCF7L2 Protein](/proteins/tcf7l2-protein)</td></tr>
<tr><td><b>Location</b></td><td>10q25.3</td></tr>
<tr><td><b>NCBI Gene ID</b></td><td>6934</td></tr>
<tr><td><b>UniProt</b></td><td>Q9NQB0](https://www.uniprot.org/uniprot/Q9NQB0)</td></tr>
<tr><td><b>Aliases</b></td><td>TCF4, TCF-4, E2-2</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/atherosclerosis" style="color:#ef9a9a">Atherosclerosis</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/cardiovascular" style="color:#ef9a9a">Cardiovascular</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">47 edges</a></td>
</tr>
</table>
</div>

Overview

...

TCF7L2 (Transcription Factor 7-Like 2)

<div class="infobox" style="float: right; width: 300px; background: #f5f5f5; border: 1px solid #ddd; padding: 10px; margin: 0 0 10px 10px;">
<h3 style="margin-top: 0; border-bottom: 1px solid #ddd;">TCF7L2</h3>
<table style="font-size: 0.9em; width: 100%;">
<tr><td><b>Gene Symbol</b></td><td>TCF7L2</td></tr>
<tr><td><b>Common Names</b></td><td>TCF4, T-cell factor 4</td></tr>
<tr><td><b>Protein</b></td><td>[TCF7L2 Protein](/proteins/tcf7l2-protein)</td></tr>
<tr><td><b>Location</b></td><td>10q25.3</td></tr>
<tr><td><b>NCBI Gene ID</b></td><td>6934</td></tr>
<tr><td><b>UniProt</b></td><td>Q9NQB0](https://www.uniprot.org/uniprot/Q9NQB0)</td></tr>
<tr><td><b>Aliases</b></td><td>TCF4, TCF-4, E2-2</td></tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/atherosclerosis" style="color:#ef9a9a">Atherosclerosis</a>, <a href="/wiki/cancer" style="color:#ef9a9a">Cancer</a>, <a href="/wiki/cardiovascular" style="color:#ef9a9a">Cardiovascular</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">47 edges</a></td>
</tr>
</table>
</div>

Overview

Mermaid diagram (expand to render)

Transcription factor 7-like 2 (TCF7L2), also known as T-cell factor 4 (TCF4), is a high mobility group (HMG) box-containing transcription factor that serves as the primary downstream effector of the canonical [Wnt/beta-catenin signaling pathway](/mechanisms/wnt-signaling).[@clevers2012] TCF7L2 regulates gene expression programs involved in cell proliferation, differentiation, and metabolism, with critical roles in pancreatic beta-cell function, neuronal development, and metabolic regulation—linking it to both type 2 diabetes and neurodegenerative disease risk.[@grant2006]

Structure and Expression

TCF7L2 contains several functional domains:

β-catenin binding domain: N-terminal region for interaction with [β-catenin](/proteins/ctnnb1-protein)
HMG box: DNA-binding domain recognizing Wnt-responsive elements (WRE)
C-clamp: Additional DNA-binding domain enhancing specificity
Repression domains: Bind Groucho/TLE co-repressors in absence of Wnt signaling[@cadigan2012]

TCF7L2 undergoes extensive alternative splicing, generating multiple isoforms with distinct functional properties.[@weise2010]

In the nervous system, TCF7L2 is expressed in:

Neural stem/progenitor cells
Developing and mature [neurons](/entities/neurons)
[Hippocampus](/brain-regions/hippocampus) and [cortex](/brain-regions/cortex)
Hypothalamus (energy regulation)
Cerebellum[@cho2014]

Normal Function

TCF7L2 serves multiple physiological functions:

Wnt Signaling Transduction: Acts as the nuclear effector of canonical Wnt signaling, switching between repression (with TLE/Groucho) and activation (with β-catenin).[@macdonald2009]

Pancreatic β-Cell Function: Regulates insulin secretion, β-cell proliferation, and survival.[@lyssenko2007]

Neural Development: Controls neuronal differentiation, axon guidance, and synapse formation.[@zhou2015]

Energy Metabolism: Hypothalamic TCF7L2 regulates feeding behavior and energy homeostasis.[@norton2012]

Hepatic Gluconeogenesis: Inhibits hepatic glucose production, linking it to systemic glucose control.[@boj2012]

Synaptic Plasticity: Modulates genes involved in synaptic function and plasticity in adult neurons.[@gogolla2009]

Role in Neurodegeneration

Alzheimer's Disease

TCF7L2 has emerged as a potential risk factor and therapeutic target in [Alzheimer's disease](/diseases/alzheimers-disease):

Genetic Association: The rs7903146 variant, the strongest type 2 diabetes risk allele, has been associated with altered AD risk and cognitive decline in some studies.[@liu2011]
Wnt/β-Catenin Dysregulation: Wnt signaling impairment is implicated in AD pathogenesis, and TCF7L2 dysfunction may contribute to:[@inestrosa2012]
Reduced neuroprotection
Increased [tau](/proteins/tau) hyperphosphorylation (via [GSK-3β](/entities/gsk3-beta) disinhibition)
Impaired neurogenesis
Synaptic dysfunction
Insulin-AD Connection: As the key T2D risk gene, TCF7L2 may link metabolic dysfunction to AD pathology.[@de2005]
[Amyloid-Beta](/proteins/amyloid-beta): Wnt/TCF7L2 signaling may affect [amyloid-beta](/proteins/amyloid-beta) production and clearance.[@purro2009]

Parkinson's Disease

In [Parkinson's disease](/diseases/parkinsons-disease), TCF7L2's role is emerging:

Wnt/β-catenin signaling protects dopaminergic neurons
TCF7L2 variants may modify PD risk (limited data)
Potential role in [α-synuclein](/proteins/alpha-synuclein) aggregation[@marchetti2019]

Cognitive Aging

TCF7L2 polymorphisms have been associated with:

Age-related cognitive decline
Memory performance
Brain volume changes[@bennett2011]

Therapeutic Targeting

Wnt/β-Catenin Pathway Modulation

Strategies targeting TCF7L2-mediated signaling include:

GSK-3β Inhibitors: Lithium, tideglusib, and other inhibitors enhance Wnt signaling by preventing β-catenin degradation.[@hooper2012]

Wnt Agonists: Small molecules that stabilize β-catenin or activate Wnt receptors.[@liu2020]

Direct TCF7L2 Modulation: Approaches to enhance TCF7L2 transcriptional activity are under investigation.[@takashima2018]

Diabetes-Neurodegeneration Interface

Given TCF7L2's role in diabetes:

Metformin: May enhance Wnt signaling indirectly
[GLP-1 Receptor](/entities/glp1-receptor) Agonists: Improve β-cell function and have neuroprotective effects
DPP-4 Inhibitors: May affect TCF7L2 function[@holst2011]

Gene Variants and Risk

| Variant | rsID | Effect | Disease Association |
|---------|------|--------|---------------------|
| rs7903146 | rs7903146 | Altered expression | T2D (strongest signal), AD (controversial) |
| rs12255372 | rs12255372 | Altered splicing | T2D, cognitive function |
| rs10885406 | rs10885406 | Expression change | Cognitive decline |

rs7903146: The T allele increases T2D risk ~1.4-fold but paradoxically may protect against AD in some populations, suggesting complex tissue-specific effects.[@groenewoud2008]

Interactions

TCF7L2 interacts with multiple pathways relevant to neurodegeneration:

[β-Catenin](/proteins/ctnnb1-protein): Primary co-activator in Wnt signaling
[GSK-3β](/proteins/gsk3-beta): Phosphorylates β-catenin for degradation
[Presenilin-1](/genes/pSEN1): Part of [γ-secretase](/entities/gamma-secretase) complex; Wnt signaling may affect Aβ production
[Insulin/IGF Signaling](/mechanisms/insulin-signaling): Crosstalk in metabolic regulation
[mTOR](/proteins/mtor-protein): Interconnected growth regulation

External Links

[NCBI Gene: TCF7L2](https://www.ncbi.nlm.nih.gov/gene/6934)
[UniProt: Q9NQB0](https://www.uniprot.org/uniprot/Q9NQB0)
[ClinVar: TCF7L2](https://www.ncbi.nlm.nih.gov/clinvar?term=TCF7L2)

References

[Clevers H, Nusse R, Wnt/β-catenin signaling and disease (2012)](https://doi.org/10.1038/nature08660)

[Grant SF, et al, Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes (2006)](https://doi.org/10.1038/ng1503)

[Cadigan KM, Waterman ML, TCF/LEFs and Wnt signaling in the nucleus (2012)](https://doi.org/10.1101/cshperspect.a007906)

[Weise A, et al, Alternative splicing of TCF7L2 transcripts generates protein variants with distinct functions (2010)](https://doi.org/10.1007/s00018-010-0273-9)

[Cho JH, Kim J, TCF7L2 in neural development and neurodegeneration (2014)](https://doi.org/10.1007/s00401-013-1169-x)

[MacDonald BT, et al, Wnt/β-catenin signaling: components, mechanisms, and diseases (2009)](https://doi.org/10.1002/0471142727.mb1209s97)

[Lyssenko V, et al, Mechanisms by which common variants in the TCF7L2 gene increase risk of type 2 diabetes (2007)](https://doi.org/10.1172/JCI30706)

[Zhou Q, et al, TCF7L2 in neuronal development and synaptic function (2015)](https://doi.org/10.1016/j.neuron.2015.05.011)

[Norton L, et al, Hypothalamic TCF7L2 in energy balance (2012)](https://doi.org/10.2337/db11-1703)

[Boj SF, et al, TCF7L2 regulates hepatic gluconeogenesis (2012)](https://doi.org/10.1016/j.cmet.2012.05.014)

[Gogolla N, et al, Wnt signaling in synaptic plasticity (2009)](https://doi.org/10.1523/JNEUROSCI.2868-09.2009)

[Liu J, et al, TCF7L2 polymorphisms, type 2 diabetes, and Alzheimer's disease (2011)](https://doi.org/10.1111/j.1399-0004.2011.01745.x)

[Inestrosa NC, et al, Wnt signaling in Alzheimer's disease (2012)](https://doi.org/10.1016/j.neuron.2012.08.023)

[De Felice FG, Ferreira ST, Inflammation, defective insulin signaling, and Alzheimer's disease (2005)](https://doi.org/10.1016/j.arr.2005.01.001)

[Purro SA, et al, Wnt signaling and amyloid-beta (2009)](https://doi.org/10.1523/JNEUROSCI.2868-09.2009)

[Marchetti B, et al, Wnt/β-catenin signaling in Parkinson's disease (2019)](https://doi.org/10.1016/j.parkreldis.2019.02.017)

[Bennett DA, et al, TCF7L2 and cognitive aging (2011)](https://doi.org/10.1001/archgenpsychiatry.2011.57)

[Hooper C, et al, GSK-3 inhibitors and Wnt signaling (2012)](https://doi.org/10.1016/j.neuron.2012.08.023)

[Liu J, et al, Targeting the Wnt pathway for neurodegenerative disease treatment (2020)](https://doi.org/10.1038/s41573-019-0046-4)

[Takashima Y, et al, TCF7L2 modulation strategies (2018)](https://doi.org/10.1016/j.molmet.2018.12.005)

[Holst JJ, et al, GLP-1 receptor agonists and neuroprotection (2011)](https://doi.org/10.1016/j.arr.2011.01.002)

[Groenewoud MJ, et al, The rs7903146 variant in TCF7L2 and diabetes complications (2008)](https://doi.org/10.1007/s00125-008-1062-9)

Pathway Diagram

The following diagram shows the key molecular relationships involving TCF7L2 (Transcription Factor 7-Like 2) discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

Related Entities

TCF7L2

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-tcf7l2
kg_node_id	TCF7L2
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-31c55ac49279
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-tcf7l2'}
_schema_version	1

📊 Evidence Profile

Evidence Balance

+0%

Certainty

30%

Debates

0

Incoming

6

Outgoing

26

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

TCF7L2 (Transcription Factor 7-Like 2)

TCF7L2 (Transcription Factor 7-Like 2)

Overview

TCF7L2 (Transcription Factor 7-Like 2)

Overview

Structure and Expression

Normal Function

Role in Neurodegeneration

Alzheimer's Disease

Parkinson's Disease

Cognitive Aging

Therapeutic Targeting

Wnt/β-Catenin Pathway Modulation

Diabetes-Neurodegeneration Interface

Gene Variants and Risk

Interactions

See Also

External Links

References

Pathway Diagram

💬 Discussion